Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

midwives

- PMLiVE

Sanofi ships synthetic malaria jab

French manufacturer says Gates Foundation-funded venture could widen treatment

- PMLiVE

Sanofi cuts $925m deal for MannKind’s inhaled insulin

French company bolsters diabetes business with Afrezza collaboration

Sanofi reception

Sanofi asks Emcure to sell its cancer drugs in India

Will hand over marketing of Taxotere, Jevtana, Fludara and Fasturtec

Sanofi reception

Sanofi and Regeneron pay $67.5m to speed alirocumab review

Buy FDA priority review voucher from BioMarin

- PMLiVE

European social network HealthUnlocked expands to US

Also adds new partners including Hepatitis Foundation International

- PMLiVE

Social media – part of the routine

The necessity of a social media engagement strategy for pharma companies

dengue fever mosquito

Sanofi’s dengue vaccine could debut in 2015

End in sight after 20-year wait for first effective vaccine

- PMLiVE

FDA to review Sanofi’s Lantus successor

Decision on company’s next generation insulin Toujeo expected early next year

Boehringer continues award-winning ChatAFib tweet chat

Its next social media discussion follows the programme's Communiqué win

Healthcare marketing compliance in the UK – prevention beats cure

UK's MHRA gives its views on rep training, pharma advertising and social media

- PMLiVE

Comms agencies “intend to do right” by Wikipedia

Ogilvy & Mather, FleishmanHillard, Weber Shandwick and more sign statement on online encyclopaedia

- PMLiVE

ADA: Novo says switching to Tresiba could reduce NHS costs

Real world data backs insulin’s ability to reduce hypoglycaemia in people with diabetes

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links